| abstract |
The present invention belongs to the field of medicine, and provides a quinoline compound or a pharmaceutically acceptable salt thereof for the treatment of Ewing's sarcoma, in particular the compound (I) or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment of Ewing's sarcoma. Provided are the use of a salt, and the use of compound (I), or a pharmaceutically acceptable salt thereof, in combination with a second therapeutic agent in the manufacture of a combination medicament for the treatment of Ewing's sarcoma. The chemical name of compound I is 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine . |